Graphene Substrates Promote the Differentiation of Inner Ear Lgr5+ Progenitor Cells Into Hair Cells.
differentiation
graphene
hair cell regeneration
proliferation
sensorineural hearing loss
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
04
2022
accepted:
03
06
2022
entrez:
11
7
2022
pubmed:
12
7
2022
medline:
12
7
2022
Statut:
epublish
Résumé
The ideal treatment for sensory hearing loss is to regenerate inner ear hair cells (HCs) through stem cell therapy, thereby restoring the function and structure of the cochlea. Previous studies have found that Lgr5+ supporting cells (SCs) in the inner ear can regenerate HCs, thus being considered inner ear progenitor cells. In addition to traditional biochemical factors, physical factors such as electrical conductivity also play a crucial role in the regulation of stem cell proliferation and differentiation. In this study, the graphene substrates were used to culture Lgr5+ progenitor cells and investigated their regulatory effects on cells. It was demonstrated that the graphene substrates displayed great cytocompatibility for Lgr5+ progenitors and promoted their sphere-forming ability. Moreover, more Myosin7a+ cells were found on the graphene substrates compared with tissue culture polystyrene (TCPS). These results suggest that graphene is an efficient interface that can promote the differentiation of Lgr5+ progenitors into HCs, which is great significance for its future application in combination with Lgr5+ cells to regenerate HCs in the inner ear.
Identifiants
pubmed: 35814013
doi: 10.3389/fbioe.2022.927248
pii: 927248
pmc: PMC9256972
doi:
Types de publication
Journal Article
Langues
eng
Pagination
927248Informations de copyright
Copyright © 2022 Ding, Hu, Cheng, Zhang, Lu, Gao, Cheng, Wang, Qian, Zhang, Chai, Gao and Huang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8167-72
pubmed: 22562792
J Assoc Res Otolaryngol. 2011 Aug;12(4):455-69
pubmed: 21472479
Nat Genet. 2008 Nov;40(11):1291-9
pubmed: 18849992
Neurochem Int. 2021 Jul;147:105005
pubmed: 33667593
Neuron. 2011 Aug 11;71(3):389-405
pubmed: 21835338
Hear Res. 2011 Mar;273(1-2):72-9
pubmed: 20488231
Oncotarget. 2016 Jul 5;7(27):41123-41141
pubmed: 27070092
Adv Exp Med Biol. 2018;1064:181-193
pubmed: 30471033
Adv Mater. 2011 Sep 22;23(36):H263-7
pubmed: 21823178
Nature. 2007 Oct 25;449(7165):1003-7
pubmed: 17934449
J Neurosci. 1990 Aug;10(8):2502-12
pubmed: 2388077
Biomater Sci. 2019 Aug 20;7(9):3534-3551
pubmed: 31250854
Nat Commun. 2015 Apr 07;6:6613
pubmed: 25849379
Nanomedicine (Lond). 2020 Jun;15(14):1411-1417
pubmed: 32508272
Biomaterials. 2018 Feb;155:236-250
pubmed: 29195230
J Photochem Photobiol B. 2020 Mar;204:111587
pubmed: 32062387
Science. 1988 Jun 24;240(4860):1772-4
pubmed: 3381100
Acta Biomater. 2022 Feb;139:105-117
pubmed: 33348061
Colloids Surf B Biointerfaces. 2020 Jan 1;185:110596
pubmed: 31707226
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13851-6
pubmed: 23918377
Nat Commun. 2018 Oct 2;9(1):4027
pubmed: 30279445
Sci Adv. 2019 Apr 17;5(4):eaav7803
pubmed: 31001589
Front Mol Neurosci. 2019 Nov 06;12:264
pubmed: 31780893
Int J Nanomedicine. 2021 Aug 30;16:5955-5980
pubmed: 34511900
Stem Cell Reports. 2014 Feb 20;2(3):311-22
pubmed: 24672754
Adv Exp Med Biol. 2018;1107:129-142
pubmed: 29882208
Hear Res. 2013 Mar;297:42-51
pubmed: 23321648
Cell Death Dis. 2016 Mar 10;7:e2136
pubmed: 26962686
Biomaterials. 2016 Nov;106:193-204
pubmed: 27566868
Drug Deliv. 2018 Nov;25(1):1033-1043
pubmed: 30799660
Regen Biomater. 2021 Jun 25;8(4):rbab032
pubmed: 34188955
Cell Death Dis. 2020 Oct 24;11(10):913
pubmed: 33099575
Front Mol Neurosci. 2021 Oct 05;14:729625
pubmed: 34675775
Macromol Biosci. 2021 Jan;21(1):e2000123
pubmed: 33015992
EMBO J. 2015 Apr 15;34(8):987-1008
pubmed: 25766254